|
Graeme Currie, Ph.D. was recently named vice president of Clinical Operations at PDL BioPharma in August 2006 after serving as the Senior Director of Clinical Operations since October 2005. Before joining PDL BioPharma, Dr. Currie was director of clinical research at Gilead Sciences where he managed clinical research activities for Hepsera (Adefovir Dipivoxil). Dr. Currie has 15 years of experience in clinical operations and has held clinical research positions with Wellcome Research Laboratories, Quintiles (BRI International Ltd.) and most recently Ipsen International where he managed clinical programs worldwide for a somatostatin analogue in two indications portal hypertension and acromegaly. Dr. Currie holds a Ph.D. from the Aston University in the United Kingdom.
| 